Annual report pursuant to Section 13 and 15(d)

Shareholders' Equity (Tables)

v3.20.1
Shareholders' Equity (Tables)
12 Months Ended
Dec. 31, 2019
Equity [Abstract]  
Schedule of warrants

    Shares Underlying Warrants     Weighted Average Exercise Price     Weighted Average Remaining Contractual Life (years)     Aggregate Intrinsic Value  
Outstanding at January 1, 2018     1,340,869     $ 5.07       4.03     $ -  
Granted     1,288,599       5.42                  
Outstanding at December 31, 2018     2,629,468       5.24       3.58       -  
Granted     141,333       5.62                  
Forfeited/cancelled     (25,000 )     7.39                  
Outstanding and exercisable at December 31, 2019     2,745,801     $ 5.24       2.58     $ -  
Schedule of stock option activity

    Shares Underlying Options     Weighted Average Exercise Price     Weighted Average Remaining Contractual Life (years)     Aggregate Intrinsic Value  
Outstanding at January 1, 2018     1,803,094     $ 4.41       8.86     $ 421  
Granted     812,000       4.16                  
Exercised     (15,292 )     3.31               6  
Forfeited/cancelled     (79,701 )    

4.63

             

1

 
Outstanding at December 31, 2018     2,520,101       4.32       8.72       -  
Granted     1,242,144       4.02                  
Exercised     (416 )     3.78               *  
Forfeited/cancelled     (245,297 )     4.24                  
Outstanding at December 31, 2019     3,516,532     $ 4.22       7.91     $ -  
*represents amount less than $1,000
                               

Schedule of option pricing model using weighted average assumptions

    For the year ended December 31,  
    2019     2018  
Expected term, in years     5.8       5.8  
Expected volatility     72.89 %     68.72 %
Risk-free interest rate     2.34 %     3.01 %
Dividend yield     -       -  
Grant date fair value   $ 2.58     $ 2.59  
Schedule of restricted stock unit awards activity

    Number of Shares     Aggregate
Weighted Average Grant Date Fair Value
 
Nonvested at December 31, 2018     165,000     $ 810  
Granted     76,112       329  
Vested     (55,523 )     (264 )
Nonvested at December 31, 2019     185,589     $ 875  

Schedule of share based compensation
  December 31,  
    2019     2018  
Research and development   $ 697     $ 170  
Sales and marketing     325       158  
General and administrative     2,183       2,147  
Total (1), (2)   $ 3,205     $ 2,475  

 

(1) As of December 31, 2019 and 2018, the Company recorded a prepaid expense in the amount of $0 and $344, respectively, for the value of vested warrants for future services to be rendered.

 

(2) As of December 31, 2019 and 2018, the Company recorded a warrant liability in the amount of $0 and $22, respectively, for the value of warrants to be issued for services provided.